Nasal spray COVID-19 vaccine booster study for healthy adults
Part of Infections, Lungs & breathing clinical trials.
This study tests a new nasal spray COVID-19 vaccine to see how it compares to an mRNA booster shot. It is for healthy adults who have already had at least 3 doses of an mRNA COVID-19 vaccine (or 2 doses plus a confirmed COVID infection) and are looking for a needle-free booster option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 55 years old (phase 1) or 60 years old (phase 2).
- You have a body mass index (BMI) between 18.5 and 30, meaning a healthy weight range.
- You have already had at least 3 doses of an mRNA COVID-19 vaccine, with your last booster at least 6 months ago. Or you had 2 mRNA doses and a confirmed COVID infection at least 6 months ago.
- You are in good general health, with no serious medical conditions like chronic rhinitis (stuffy nose), nasal problems, or a history of nosebleeds.
- You are available to stay near the study site for the whole trial and agree to use barrier methods (like masks and hand washing) against COVID-19.
- If you are a woman who can become pregnant, you must use highly effective birth control and not be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a nasal spray booster for people who have already had 2-3 doses of COVID-19 inactivated vaccine. It studies if the spray is safe and boosts your immune system. You can join if you are healthy, have not had COVID-19 in the last 3 months, and had your last vaccine dose more than 6 months ago.
This trial tests a new nasal spray COVID-19 booster vaccine. It aims to see if the vaccine is safe and produces a strong immune response when given through the nose and inhaled, in people who have already been vaccinated.
This trial tests a new nasal spray booster for COVID-19 in adults 18–64 who have already had a primary vaccine series and at least one booster. The goal is to see if it is safe and triggers a good immune response.
This study tests new COVID-19 booster vaccine candidates in healthy adults who previously received mRNA COVID-19 vaccines. Researchers will monitor safety and how well your immune system responds to help develop better COVID-19 protection.
This study compares how well the mRNA Covid-19 vaccine works when given through different methods (like a needle or a jet injector). It may help find a more comfortable or effective way to get vaccinated.
This trial tests a next-generation COVID-19 vaccine given as an inhaled mist. It is for adults who have already had at least 3 doses of an mRNA COVID vaccine and are looking for a potentially stronger or longer-lasting immune response.
Hear when a new Healthy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.